Data as of Mar 14
| -0.03 / -0.48%|
The 1 analysts offering 12-month price forecasts for Biota Pharmaceuticals Inc have a median target of 7.00, with a high estimate of 7.00 and a low estimate of 7.00. The median estimate represents a +13.64% increase from the last price of 6.16.
The current consensus among 1 polled investment analysts is to Buy stock in Biota Pharmaceuticals Inc. This rating has held steady since March, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.